Kim Malmborg remembers the day she walked into the obesity clinic weighing 148 kilograms. The specialized treatment center in Malmö gave her tools and understanding that obesity is a disease, not a personal failure. Now eight years later, that same clinic is closing its doors to most patients.
"The treatment gave me tools and understanding that obesity is a disease," Malmborg recalls. "I feel sorrow that they're treating an entire patient group this way."
The clinic provided something unique in Swedish healthcare. Patients worked with obesity experts and participated in group weight loss therapy. They learned to understand themselves and their behaviors in a supportive environment. But clinic director Fredrik von Wowern made the difficult decision to end this care model.
"We see the model doesn't have the intended effect now that potent medications and surgery exist for patients with serious obesity," von Wowern explained in a statement.
Moving forward, the Malmö clinic will primarily accept patients with severe or very severe obesity. Other patients will be referred to primary care centers. There, seriously ill obesity patients might receive medication or surgery, but many will be left without treatment and forced to pay for medicine or operations themselves.
This shift represents a broader trend in Swedish healthcare toward pharmaceutical and surgical solutions over behavioral and therapeutic approaches. Sweden's universal healthcare system faces constant pressure to balance comprehensive care with cost efficiency.
"There are people who don't want surgery," Malmborg notes. "There are people who can't afford medication. This will result in people going without care, and that's not okay."
The closure raises important questions about how Sweden treats chronic conditions. Obesity affects nearly one in five Swedish adults according to recent public health reports. The condition carries significant health risks including diabetes, heart disease, and joint problems.
Many patients valued the clinic's psychological support component. Group therapy helped them understand emotional eating patterns and develop healthier relationships with food. This holistic approach distinguished it from standard weight loss programs.
Von Wowern suggests the price of weight loss medications will likely decrease within a few years, potentially making them more accessible. But for now, the transition leaves a gap in Sweden's healthcare landscape.
The change particularly impacts southern Sweden, where Malmö serves as a major healthcare hub. Patients from across Skåne county previously accessed the specialized clinic. Now they must navigate primary care systems that may lack specific obesity expertise.
This situation reflects wider Swedish society trends toward medical solutions for complex health issues. As new pharmaceuticals emerge, healthcare providers face difficult choices about which treatments to prioritize within budget constraints.
For international readers, Sweden's healthcare system typically provides comprehensive coverage, but this case shows how even robust systems must make tough decisions about resource allocation. The clinic's transformation demonstrates how medical advances can reshape entire treatment approaches.
What happens to patients who don't qualify as severe cases but still need support? They'll need to find alternatives through primary care or private options. This could mean longer wait times or additional costs for those seeking help with weight management.
The Malmö clinic's evolution will be watched closely by healthcare providers across Sweden. Other regions may consider similar changes if medication costs decrease and surgical options improve. For now, patients like Kim Malmborg worry about the human impact of these healthcare decisions.